Ipilimumab alone or in combination with nivolumab after progression on anti-PD-1 therapy in advanced melanoma

Lisa Zimmer, Susmitha Apuri, Zeynep Eroglu, Lisa A. Kottschade, Andrea Forschner, Ralf Gutzmer, Max Schlaak, Lucie Heinzerling, Angela M. Krackhardt, Carmen Loquai, Svetomir Nenad Markovic, Richard W Joseph, Kelly Markey, Jochen S. Utikal, Carsten Weishaupt, Simone M. Goldinger, Vernon K. Sondak, Jonathan S. Zager, Dirk Schadendorf, Nikhil I. Khushalani

Research output: Contribution to journalArticle

63 Scopus citations

Fingerprint Dive into the research topics of 'Ipilimumab alone or in combination with nivolumab after progression on anti-PD-1 therapy in advanced melanoma'. Together they form a unique fingerprint.

Medicine & Life Sciences